Sato, Naru https://orcid.org/0000-0003-0452-3194
Goyama, Susumu https://orcid.org/0000-0002-9339-1826
Chang, Yu-Hsuan
Miyawaki, Masashi
Fujino, Takeshi
Koide, Shuhei
Denda, Tamami
Liu, Xiaoxiao https://orcid.org/0000-0002-0023-4013
Ueda, Koji https://orcid.org/0000-0001-9066-4959
Yamamoto, Keita
Asada, Shuhei https://orcid.org/0000-0001-6116-7996
Takeda, Reina https://orcid.org/0000-0002-4233-8806
Yonezawa, Taishi
Tanaka, Yosuke https://orcid.org/0000-0002-8538-0916
Honda, Hiroaki https://orcid.org/0000-0002-4617-9670
Ota, Yasunori
Shibata, Takuma
Sekiya, Motohiro https://orcid.org/0000-0002-5170-9699
Isobe, Tomoya https://orcid.org/0000-0002-3487-3307
Lamagna, Chrystelle
Masuda, Esteban
Iwama, Atsushi https://orcid.org/0000-0001-9410-8992
Shimano, Hitoshi
Inoue, Jun-ichiro https://orcid.org/0000-0001-6389-7036
Miyake, Kensuke https://orcid.org/0000-0001-6629-226X
Kitamura, Toshio https://orcid.org/0000-0001-7855-1767
Article History
Received: 3 May 2024
Accepted: 30 October 2024
First Online: 9 December 2024
Competing interests
: E.M. and C.L. own stock in and are employees of Rigel Pharmaceuticals, Inc. The other authors declare no competing interests.